Cargando…

Modeling the Orthosteric Binding Site of the G Protein-Coupled Odorant Receptor OR5K1

[Image: see text] With approximately 400 encoding genes in humans, odorant receptors (ORs) are the largest subfamily of class A G protein-coupled receptors (GPCRs). Despite its high relevance and representation, the odorant-GPCRome is structurally poorly characterized: no experimental structures are...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicoli, Alessandro, Haag, Franziska, Marcinek, Patrick, He, Ruiming, Kreißl, Johanna, Stein, Jörg, Marchetto, Alessandro, Dunkel, Andreas, Hofmann, Thomas, Krautwurst, Dietmar, Di Pizio, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091413/
https://www.ncbi.nlm.nih.gov/pubmed/36696962
http://dx.doi.org/10.1021/acs.jcim.2c00752
Descripción
Sumario:[Image: see text] With approximately 400 encoding genes in humans, odorant receptors (ORs) are the largest subfamily of class A G protein-coupled receptors (GPCRs). Despite its high relevance and representation, the odorant-GPCRome is structurally poorly characterized: no experimental structures are available, and the low sequence identity of ORs to experimentally solved GPCRs is a significant challenge for their modeling. Moreover, the receptive range of most ORs is unknown. The odorant receptor OR5K1 was recently and comprehensively characterized in terms of cognate agonists. Here, we report two additional agonists and functional data of the most potent compound on two mutants, L104(3.32) and L255(6.51). Experimental data was used to guide the investigation of the binding modes of OR5K1 ligands into the orthosteric binding site using structural information from AI-driven modeling, as recently released in the AlphaFold Protein Structure Database, and from homology modeling. Induced-fit docking simulations were used to sample the binding site conformational space for ensemble docking. Mutagenesis data guided side chain residue sampling and model selection. We obtained models that could better rationalize the different activity of active (agonist) versus inactive molecules with respect to starting models and also capture differences in activity related to minor structural differences. Therefore, we provide a model refinement protocol that can be applied to model the orthosteric binding site of ORs as well as that of GPCRs with low sequence identity to available templates.